Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)

Federal Grant Forecasted Active

Program Number (CFDA) PAR-26-132

Agency National Institutes of Health

Program Type Forecasted

Total Funding $0

Status Active

Opportunity #: PAR-26-132. Agency: National Institutes of Health. Status: Forecasted Posted: 03/04/2026.

🎯 Get GovCon Intel Free →

Get Federal ContractingIntelligence — Free